cbdMD, Inc.
YCBD
$0.49
-$0.01-1.56%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.01% | 2.00% | -0.66% | -1.50% | -7.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.01% | 2.00% | -0.66% | -1.50% | -7.80% |
| Cost of Revenue | 20.01% | 10.06% | 1.94% | -3.53% | -2.18% |
| Gross Profit | 3.68% | -2.87% | -2.28% | -0.23% | -11.04% |
| SG&A Expenses | 13.53% | 6.90% | -2.14% | -9.74% | -18.41% |
| Depreciation & Amortization | -11.62% | -10.37% | -7.78% | -2.06% | -24.72% |
| Other Operating Expenses | 23.61% | 120.71% | 18.68% | 17.12% | -88.16% |
| Total Operating Expenses | 14.48% | 8.62% | -0.46% | -6.34% | -21.49% |
| Operating Income | -61.89% | -110.72% | -1.14% | 34.77% | 69.51% |
| Income Before Tax | -90.80% | -1,572.80% | 13.00% | 44.84% | 92.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -90.80% | -1,572.80% | 13.00% | 44.84% | 92.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -90.80% | -1,572.80% | 13.00% | 44.84% | 92.21% |
| EBIT | -61.89% | -110.72% | -1.14% | 34.77% | 69.51% |
| EBITDA | -193.89% | -1,371.97% | -10.00% | 52.14% | 85.26% |
| EPS Basic | 93.89% | 93.24% | 85.13% | 78.96% | 96.67% |
| Normalized Basic EPS | 76.40% | 82.66% | 84.29% | 88.28% | 96.01% |
| EPS Diluted | 93.89% | 93.24% | 85.13% | 78.96% | 96.67% |
| Normalized Diluted EPS | 76.40% | 82.66% | 84.29% | 88.28% | 96.01% |
| Average Basic Shares Outstanding | 382.48% | 1,141.44% | 945.52% | 649.51% | 515.06% |
| Average Diluted Shares Outstanding | 382.48% | 1,141.44% | 945.52% | 649.51% | 515.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |